Cantel Medical Board Of Directors Authorizes Regular Semiannual Dividend

LITTLE FALLS, N.J., June 18, 2015 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN) announced today that its Board of Directors authorized a regular semiannual cash dividend of $0.05 per outstanding share of the Company's Common Stock. The dividend is payable on July 31, 2015 to shareholders of record at the close of business on July 17, 2015.

About Cantel Medical Corp.

Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives.  Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, and hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cantel-medical-board-of-directors-authorizes-regular-semiannual-dividend-300101420.html

SOURCE Cantel Medical Corp.